EZH2 is a signature biomarker of aggressive breast cancer.

Authors
  • C.G. Kleer
  • R. Shen
  • S. Varambally
  • S.A. Tomlins
  • D. Ghosh
  • A.P. Otte
  • D.F. Hayes
  • D.C. Sgroi
  • M.S. Sabel
  • M.A. Rubin
  • A.M. Chinnaiyan
Publication date 2003
Journal Proceedings of the National Academy of Sciences of the United States of America
Volume | Issue number 100
Pages (from-to) 11606-11611
Organisations
  • Faculty of Science (FNWI) - Swammerdam Institute for Life Sciences (SILS)
Document type Article
Published at https://doi.org/10.1073/pnas.1933744100
Permalink to this page
Back